Skip to main content
Top
Gepubliceerd in:

01-05-2008

Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools

Auteurs: Robert P. Finger, Monika Fleckenstein, Frank G. Holz, Hendrik P. N. Scholl

Gepubliceerd in: Quality of Life Research | Uitgave 4/2008

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Age-related macular degeneration (AMD) has a considerable impact on older adults’ independence and autonomy. Recently, patient reported outcomes (PROs) such as QoL have been met with increasing interest by the scientific community, healthcare payers and planners. Against this background, the multitude of psychometric tools used to measure QoL in AMD was reviewed.

Methods

A search of the literature from 1990 onwards yielded 355 results, out of which 58 publications were included in the review. Data regarding design, validation and extent of utilization were obtained where available.

Results

The National Eye Institute–Visual Function Questionnaire (NEI VFQ-25-item) was found to be the most often used (29% of studies) and best validated psychometric tool, followed by the Visual Function Questionnaire (VF-14; 17%), and the Impact of Vision Impairment Profile (IVI; 9%). Most tools that were identified have been validated for the use in AMD patients.

Conclusion

Psychometric tools specifically designed to measure vision-related quality of life are well equipped and validated to measure QoL in AMD. More recent developments such as the Macular Disease-dependent Quality of Life (MacDQoL) questionnaire might be able to depict dimensions of vision-related QoL in greater depth. Future studies should endeavour to use a suggested standard when gathering data on vision related QoL, allowing for international comparisons.
Literatuur
1.
go back to reference Fine S. L., Berger J. W., Maguire M. G., & Ho A. C. (2000). Age-related macular degeneration. The New England Journal of Medicine 342, 483–492.PubMedCrossRef Fine S. L., Berger J. W., Maguire M. G., & Ho A. C. (2000). Age-related macular degeneration. The New England Journal of Medicine 342, 483–492.PubMedCrossRef
2.
go back to reference Trautner C., Haastert B., Richter B., Berger M., & Giani G. (2003). Incidence of blindness in southern Germany due to glaucoma and degenerative conditions. Investigative Ophthalmology & Visual Science, 44, 1031–1034.CrossRef Trautner C., Haastert B., Richter B., Berger M., & Giani G. (2003). Incidence of blindness in southern Germany due to glaucoma and degenerative conditions. Investigative Ophthalmology & Visual Science, 44, 1031–1034.CrossRef
3.
go back to reference Birk T., Hickl S., Wahl H. W., Miller D., Kammerer A., Holz F., Becker S., & Volcker H. E. (2004). Development and pilot evaluation of a psychosocial intervention program for patients with age-related macular degeneration. Gerontologist, 44, 836–843.PubMed Birk T., Hickl S., Wahl H. W., Miller D., Kammerer A., Holz F., Becker S., & Volcker H. E. (2004). Development and pilot evaluation of a psychosocial intervention program for patients with age-related macular degeneration. Gerontologist, 44, 836–843.PubMed
4.
go back to reference de Jong P. T. (2006). Age-related macular degeneration. The New England Journal of Medicine, 355, 1474–1485.PubMedCrossRef de Jong P. T. (2006). Age-related macular degeneration. The New England Journal of Medicine, 355, 1474–1485.PubMedCrossRef
5.
go back to reference Holz F. G., Pauleikhoff D., Klein R., & Bird A. C. (2004). Pathogenesis of lesions in late age-related macular disease. American Journal of Ophthalmology, 137, 504–510.PubMedCrossRef Holz F. G., Pauleikhoff D., Klein R., & Bird A. C. (2004). Pathogenesis of lesions in late age-related macular disease. American Journal of Ophthalmology, 137, 504–510.PubMedCrossRef
6.
go back to reference Eter N., Krohne T. U., & Holz F. G. (2006). New pharmacologic approaches to therapy for age-related macular degeneration. BioDrugs, 20, 167–179.PubMedCrossRef Eter N., Krohne T. U., & Holz F. G. (2006). New pharmacologic approaches to therapy for age-related macular degeneration. BioDrugs, 20, 167–179.PubMedCrossRef
7.
go back to reference The Age-related Eye Disease Study Research Group. (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology, 119, 1417–1436. The Age-related Eye Disease Study Research Group. (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology, 119, 1417–1436.
8.
go back to reference Slakter J. S., & Stur M. (2005). Quality of life in patients with age-related macular degeneration: Impact of the condition and benefits of treatment. Survey of Ophthalmology, 50, 263–273.PubMedCrossRef Slakter J. S., & Stur M. (2005). Quality of life in patients with age-related macular degeneration: Impact of the condition and benefits of treatment. Survey of Ophthalmology, 50, 263–273.PubMedCrossRef
9.
go back to reference Brody B. L., Gamst A. C., Williams R. A., Smith A. R., Lau P. W., Dolnak D., Rapaport M. H., Kaplan R. M., & Brown S. I. (2001). Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology, 108, 1893–1900, discussion 1900–1891.PubMedCrossRef Brody B. L., Gamst A. C., Williams R. A., Smith A. R., Lau P. W., Dolnak D., Rapaport M. H., Kaplan R. M., & Brown S. I. (2001). Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology, 108, 1893–1900, discussion 1900–1891.PubMedCrossRef
10.
go back to reference Brody B. L., Williams R. A., Thomas R. G., Kaplan R. M., Chu R. M., & Brown S. I. (1999). Age-related macular degeneration: A randomized clinical trial of a self-management intervention. Annals of Behavioural Medicine, 21, 322–329.CrossRef Brody B. L., Williams R. A., Thomas R. G., Kaplan R. M., Chu R. M., & Brown S. I. (1999). Age-related macular degeneration: A randomized clinical trial of a self-management intervention. Annals of Behavioural Medicine, 21, 322–329.CrossRef
11.
go back to reference Williams R. A., Brody B. L., Thomas R. G., Kaplan R. M., & Brown S. I. (1998). The psychosocial impact of macular degeneration. Archives of Ophthalmology, 116, 514–520.PubMed Williams R. A., Brody B. L., Thomas R. G., Kaplan R. M., & Brown S. I. (1998). The psychosocial impact of macular degeneration. Archives of Ophthalmology, 116, 514–520.PubMed
12.
go back to reference O’Shaughnessy J. A., Wittes R. E., Burke G., Friedman M. A., Johnson J. R., Niederhuber J. E., Rothenberg M. L., Woodcock J., Chabner B. A., & Temple R. (1991). Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials. Journal of Clinical Oncology, 9, 2225–2232.PubMed O’Shaughnessy J. A., Wittes R. E., Burke G., Friedman M. A., Johnson J. R., Niederhuber J. E., Rothenberg M. L., Woodcock J., Chabner B. A., & Temple R. (1991). Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials. Journal of Clinical Oncology, 9, 2225–2232.PubMed
13.
go back to reference Committee for Medicinal Products for Human Use (CHMP). (2005). Reflection Paper on the regulatory guidance for the use of healthrelated quality of life (HRQL) measures in the evaluation of medicinal products. In: EMEA, London. Committee for Medicinal Products for Human Use (CHMP). (2005). Reflection Paper on the regulatory guidance for the use of healthrelated quality of life (HRQL) measures in the evaluation of medicinal products. In: EMEA, London.
14.
go back to reference Chassany O., Sagnier P., Marquis P., Fullerton S., & Aaronson N. (2002). Patient—reported outcomes: The example of health-related quality of life—A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Information Journal, 36, 209–238. Chassany O., Sagnier P., Marquis P., Fullerton S., & Aaronson N. (2002). Patient—reported outcomes: The example of health-related quality of life—A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Information Journal, 36, 209–238.
15.
go back to reference Cahill M. T., Banks A. D., Stinnett S. S., & Toth C. A. (2005). Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology, 112, 152–158.PubMedCrossRef Cahill M. T., Banks A. D., Stinnett S. S., & Toth C. A. (2005). Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology, 112, 152–158.PubMedCrossRef
16.
go back to reference Margolis M. K., Coyne K., Kennedy-Martin T., Baker T., Schein O., & Revicki D. A. (2002). Vision-specific instruments for the assessment of health-related quality of life and visual functioning: A literature review. Pharmacoeconomics, 20, 791–812.PubMedCrossRef Margolis M. K., Coyne K., Kennedy-Martin T., Baker T., Schein O., & Revicki D. A. (2002). Vision-specific instruments for the assessment of health-related quality of life and visual functioning: A literature review. Pharmacoeconomics, 20, 791–812.PubMedCrossRef
17.
go back to reference de Boer M. R., Moll A. C., de Vet H. C., Terwee C. B., Volker-Dieben H. J., & van Rens G. H. (2004). Psychometric properties of vision-related quality of life questionnaires: A systematic review. Ophthalmic & Physiological Optics, 24, 257–273.CrossRef de Boer M. R., Moll A. C., de Vet H. C., Terwee C. B., Volker-Dieben H. J., & van Rens G. H. (2004). Psychometric properties of vision-related quality of life questionnaires: A systematic review. Ophthalmic & Physiological Optics, 24, 257–273.CrossRef
18.
go back to reference Mangione C. M., Phillips R. S., Seddon J. M., Lawrence M. G., Cook E. F., Dailey R., & Goldman L. (1992). Development of the ‘Activities of Daily Vision Scale’. A measure of visual functional status. Medical Care, 30, 1111–1126.PubMedCrossRef Mangione C. M., Phillips R. S., Seddon J. M., Lawrence M. G., Cook E. F., Dailey R., & Goldman L. (1992). Development of the ‘Activities of Daily Vision Scale’. A measure of visual functional status. Medical Care, 30, 1111–1126.PubMedCrossRef
19.
go back to reference Pesudovs K., & Coster D. J. (1998). An instrument for assessment of subjective visual disability in cataract patients. The British Journal of Ophthalmology, 82, 617–624.PubMed Pesudovs K., & Coster D. J. (1998). An instrument for assessment of subjective visual disability in cataract patients. The British Journal of Ophthalmology, 82, 617–624.PubMed
20.
go back to reference Pesudovs K., Garamendi E., Keeves J. P., & Elliott D. B. (2003). The activities of daily vision scale for cataract surgery outcomes: Re-evaluating validity with Rasch analysis. Investigative Ophthalmology & Visual Science 44, 2892–2899.CrossRef Pesudovs K., Garamendi E., Keeves J. P., & Elliott D. B. (2003). The activities of daily vision scale for cataract surgery outcomes: Re-evaluating validity with Rasch analysis. Investigative Ophthalmology & Visual Science 44, 2892–2899.CrossRef
21.
go back to reference Hart P. M., Chakravarthy U., Stevenson M. R., & Jamison J. Q. (1999). A vision specific functional index for use in patients with age related macular degeneration. The British Journal of Ophthalmology, 83, 1115–1120.PubMed Hart P. M., Chakravarthy U., Stevenson M. R., & Jamison J. Q. (1999). A vision specific functional index for use in patients with age related macular degeneration. The British Journal of Ophthalmology, 83, 1115–1120.PubMed
22.
go back to reference Hart P. M., Stevenson M. R., Montgomery A. M., Muldrew K. A., & Chakravarthy U. (2005). Further validation of the daily living tasks dependent on vision: Identification of domains. The British Journal of Ophthalmology, 89, 1127–1130.PubMedCrossRef Hart P. M., Stevenson M. R., Montgomery A. M., Muldrew K. A., & Chakravarthy U. (2005). Further validation of the daily living tasks dependent on vision: Identification of domains. The British Journal of Ophthalmology, 89, 1127–1130.PubMedCrossRef
23.
go back to reference Schmier J. K., Halpern M. T., & Covert D. (2006). Validation of the daily living tasks dependent on vision (DLTV) questionnaire in a U.S. population with age-related macular degeneration. Ophthalmic Epidemiology, 13, 137–143.PubMedCrossRef Schmier J. K., Halpern M. T., & Covert D. (2006). Validation of the daily living tasks dependent on vision (DLTV) questionnaire in a U.S. population with age-related macular degeneration. Ophthalmic Epidemiology, 13, 137–143.PubMedCrossRef
24.
go back to reference McClure M. E., Hart P. M., Jackson A. J., Stevenson M. R., & Chakravarthy U. (2000). Macular degeneration: Do conventional measurements of impaired visual function equate with visual disability? The British Journal of Ophthalmology, 84, 244–250.PubMedCrossRef McClure M. E., Hart P. M., Jackson A. J., Stevenson M. R., & Chakravarthy U. (2000). Macular degeneration: Do conventional measurements of impaired visual function equate with visual disability? The British Journal of Ophthalmology, 84, 244–250.PubMedCrossRef
25.
go back to reference Lamoureux E. L., Pallant J. F., Pesudovs K., Rees G., Hassell J. B., & Keeffe J. E. (2007). The impact of vision impairment questionnaire: An assessment of its domain structure using confirmatory factor analysis and rasch analysis. Investigative Ophthalmology & Visual Science, 48, 1001–1006.CrossRef Lamoureux E. L., Pallant J. F., Pesudovs K., Rees G., Hassell J. B., & Keeffe J. E. (2007). The impact of vision impairment questionnaire: An assessment of its domain structure using confirmatory factor analysis and rasch analysis. Investigative Ophthalmology & Visual Science, 48, 1001–1006.CrossRef
26.
go back to reference Lamoureux E. L., Pallant J. F., Pesudovs K., Hassell J. B., & Keeffe J. E. (2006). The impact of vision impairment questionnaire: An evaluation of its measurement properties using Rasch analysis. Investigative Ophthalmology & Visual Science, 47, 4732–4741.CrossRef Lamoureux E. L., Pallant J. F., Pesudovs K., Hassell J. B., & Keeffe J. E. (2006). The impact of vision impairment questionnaire: An evaluation of its measurement properties using Rasch analysis. Investigative Ophthalmology & Visual Science, 47, 4732–4741.CrossRef
27.
go back to reference Hassell J. B., Weih L. M., & Keeffe J. E. (2000). A measure of handicap for low vision rehabilitation: The impact of vision impairment profile. Clinical & Experiment Ophthalmology, 28, 156–161.CrossRef Hassell J. B., Weih L. M., & Keeffe J. E. (2000). A measure of handicap for low vision rehabilitation: The impact of vision impairment profile. Clinical & Experiment Ophthalmology, 28, 156–161.CrossRef
28.
go back to reference Mitchell J., & Bradley C. (2004). Design of an individualised measure of the impact of macular disease on quality of life (the MacDQoL). Quality of Life Research, 13, 1163–1175.PubMedCrossRef Mitchell J., & Bradley C. (2004). Design of an individualised measure of the impact of macular disease on quality of life (the MacDQoL). Quality of Life Research, 13, 1163–1175.PubMedCrossRef
29.
go back to reference Mitchell J., Wolffsohn J. S., Woodcock A., Anderson S. J., McMillan C. V., Ffytche T., Rubinstein M., Amoaku W., & Bradley C. (2005). +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life. Health and Quality of Life Outcomes, 3, 25.PubMedCrossRef Mitchell J., Wolffsohn J. S., Woodcock A., Anderson S. J., McMillan C. V., Ffytche T., Rubinstein M., Amoaku W., & Bradley C. (2005). +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life. Health and Quality of Life Outcomes, 3, 25.PubMedCrossRef
30.
go back to reference Mangione C. M., Lee P. P., Gutierrez P. R., Spritzer K., Berry S., & Hays R. D. (2001). Development of the 25-item National Eye Institute Visual Function Questionnaire. Archives of Ophthalmology, 119, 1050–1058.PubMed Mangione C. M., Lee P. P., Gutierrez P. R., Spritzer K., Berry S., & Hays R. D. (2001). Development of the 25-item National Eye Institute Visual Function Questionnaire. Archives of Ophthalmology, 119, 1050–1058.PubMed
31.
go back to reference Miskala P. H., Hawkins B. S., Mangione C. M., Bass E. B., Bressler N. M., Dong L. M., Marsh M. J., & McCaffrey L. D. (2003). Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: Findings in patients with subfoveal choroidal neovascularization–SST Report No. 1. Archives of Ophthalmology, 121, 531–539.PubMedCrossRef Miskala P. H., Hawkins B. S., Mangione C. M., Bass E. B., Bressler N. M., Dong L. M., Marsh M. J., & McCaffrey L. D. (2003). Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: Findings in patients with subfoveal choroidal neovascularization–SST Report No. 1. Archives of Ophthalmology, 121, 531–539.PubMedCrossRef
32.
go back to reference Mangione C. M., Lee P. P., Pitts J., Gutierrez P., Berry S., & Hays R. D. (1998). Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ field test investigators. Archives of Ophthalmology, 116, 1496–1504.PubMed Mangione C. M., Lee P. P., Pitts J., Gutierrez P., Berry S., & Hays R. D. (1998). Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ field test investigators. Archives of Ophthalmology, 116, 1496–1504.PubMed
33.
go back to reference Mangione C. M., Berry S., Spritzer K., Janz N. K., Klein R., Owsley C., & Lee P. P. (1998). Identifying the content area for the 51-item national eye institute visual function questionnaire: Results from focus groups with visually impaired persons. Archives of Ophthalmology, 116, 227–233.PubMed Mangione C. M., Berry S., Spritzer K., Janz N. K., Klein R., Owsley C., & Lee P. P. (1998). Identifying the content area for the 51-item national eye institute visual function questionnaire: Results from focus groups with visually impaired persons. Archives of Ophthalmology, 116, 227–233.PubMed
34.
go back to reference Steinberg E. P., Tielsch J. M., Schein O. D., Javitt J. C., Sharkey P., Cassard S. D., Legro M. W., Diener-West M., Bass E. B., & Damiano A. M., et al. (1994). The VF-14. An index of functional impairment in patients with cataract. Archives of Ophthalmology, 112, 630–638.PubMed Steinberg E. P., Tielsch J. M., Schein O. D., Javitt J. C., Sharkey P., Cassard S. D., Legro M. W., Diener-West M., Bass E. B., & Damiano A. M., et al. (1994). The VF-14. An index of functional impairment in patients with cataract. Archives of Ophthalmology, 112, 630–638.PubMed
35.
go back to reference Linder M., Chang T. S., Scott I. U., Hay D., Chambers K., Sibley L. M., & Weis E. (1999). Validity of the visual function index (VF-14) in patients with retinal disease. Archives of Ophthalmology, 117, 1611–1616.PubMed Linder M., Chang T. S., Scott I. U., Hay D., Chambers K., Sibley L. M., & Weis E. (1999). Validity of the visual function index (VF-14) in patients with retinal disease. Archives of Ophthalmology, 117, 1611–1616.PubMed
36.
go back to reference Riusala A., Sarna S., & Immonen I. (2003). Visual function index (VF-14) in exudative age-related macular degeneration of long duration. American Journal of Ophthalmology, 135, 206–212.PubMedCrossRef Riusala A., Sarna S., & Immonen I. (2003). Visual function index (VF-14) in exudative age-related macular degeneration of long duration. American Journal of Ophthalmology, 135, 206–212.PubMedCrossRef
37.
go back to reference Cassard S. D., Patrick D. L., Damiano A. M., Legro M. W., Tielsch J. M., Diener-West M., Schein O. D., Javitt J. C., Bass E. B., & Steinberg E. P. (1995). Reproducibility and responsiveness of the VF-14. An index of functional impairment in patients with cataracts. Archives of Ophthalmology, 113, 1508–1513.PubMed Cassard S. D., Patrick D. L., Damiano A. M., Legro M. W., Tielsch J. M., Diener-West M., Schein O. D., Javitt J. C., Bass E. B., & Steinberg E. P. (1995). Reproducibility and responsiveness of the VF-14. An index of functional impairment in patients with cataracts. Archives of Ophthalmology, 113, 1508–1513.PubMed
38.
go back to reference Lindblad A. S., & Clemons T. E. (2005). Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14. Archives of Ophthalmology, 123, 1207–1214.PubMedCrossRef Lindblad A. S., & Clemons T. E. (2005). Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14. Archives of Ophthalmology, 123, 1207–1214.PubMedCrossRef
39.
go back to reference Clemons T. E., Chew E. Y., Bressler S. B., & McBee W. (2003). National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10. Archives of Ophthalmology, 121, 211–217.PubMed Clemons T. E., Chew E. Y., Bressler S. B., & McBee W. (2003). National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10. Archives of Ophthalmology, 121, 211–217.PubMed
40.
go back to reference Suzukamo Y., Oshika T., Yuzawa M., Tokuda Y., Tomidokoro A., Oki K., Mangione C. M., Green J., & Fukuhara S. (2005). Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version. Health and Quality of Life Outcomes, 3, 65.PubMedCrossRef Suzukamo Y., Oshika T., Yuzawa M., Tokuda Y., Tomidokoro A., Oki K., Mangione C. M., Green J., & Fukuhara S. (2005). Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version. Health and Quality of Life Outcomes, 3, 65.PubMedCrossRef
41.
go back to reference Toprak A. B., Eser E., Guler C., Baser F. E., & Mayali H. (2005). Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25). Ophthalmic Epidemiology, 12, 259–269.PubMedCrossRef Toprak A. B., Eser E., Guler C., Baser F. E., & Mayali H. (2005). Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25). Ophthalmic Epidemiology, 12, 259–269.PubMedCrossRef
42.
go back to reference Rossi G. C., Milano G., & Tinelli C. (2003). The Italian version of the 25-item National Eye Institute Visual Function Questionnaire: Translation, validity, and reliability. Journal of Glaucoma, 12, 213–220.PubMedCrossRef Rossi G. C., Milano G., & Tinelli C. (2003). The Italian version of the 25-item National Eye Institute Visual Function Questionnaire: Translation, validity, and reliability. Journal of Glaucoma, 12, 213–220.PubMedCrossRef
43.
go back to reference Hudson H. L., Lane S. S., Heier J. S., Stulting R. D., Singerman L., Lichter P. R., Sternberg P., & Chang D. F. (2006). Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-Year results. Ophthalmology, 113, 1987–2001.PubMedCrossRef Hudson H. L., Lane S. S., Heier J. S., Stulting R. D., Singerman L., Lichter P. R., Sternberg P., & Chang D. F. (2006). Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-Year results. Ophthalmology, 113, 1987–2001.PubMedCrossRef
44.
go back to reference Fuhs A., Dasch B., Behrens T., Meister A., Krause K., Pauleikhoff D., & Hense H. W. (2005). Visual function and quality of life in patients with age-related maculopathy: Results of the Munster Age and Retina Study (MARS). Klin Monatsbl Augenheilkd, 222, 649–654.PubMedCrossRef Fuhs A., Dasch B., Behrens T., Meister A., Krause K., Pauleikhoff D., & Hense H. W. (2005). Visual function and quality of life in patients with age-related maculopathy: Results of the Munster Age and Retina Study (MARS). Klin Monatsbl Augenheilkd, 222, 649–654.PubMedCrossRef
45.
go back to reference Cahill M. T., Stinnett S. S., Banks A. D., Freedman S. F., & Toth C. A. (2005). Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration. Ophthalmology, 112, 144–151.PubMedCrossRef Cahill M. T., Stinnett S. S., Banks A. D., Freedman S. F., & Toth C. A. (2005). Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration. Ophthalmology, 112, 144–151.PubMedCrossRef
46.
go back to reference Miskala P. H., Bass E. B., Bressler N. M., Childs A. L., Hawkins B. S., Mangione C. M., & Marsh M. J. (2004). Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: Quality-of-life findings: SST report no. 12. Ophthalmology, 111, 1981–1992.PubMedCrossRef Miskala P. H., Bass E. B., Bressler N. M., Childs A. L., Hawkins B. S., Mangione C. M., & Marsh M. J. (2004). Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: Quality-of-life findings: SST report no. 12. Ophthalmology, 111, 1981–1992.PubMedCrossRef
47.
go back to reference Childs A. L., Bressler N. M., Bass E. B., Hawkins B. S., Mangione C. M., Marsh M. J., & Miskala P. H. (2004). Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: Quality-of-life findings: SST report no. 14. Ophthalmology, 111, 2007–2014.PubMedCrossRef Childs A. L., Bressler N. M., Bass E. B., Hawkins B. S., Mangione C. M., Marsh M. J., & Miskala P. H. (2004). Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: Quality-of-life findings: SST report no. 14. Ophthalmology, 111, 2007–2014.PubMedCrossRef
48.
go back to reference Scilley K., DeCarlo D. K., Wells J., & Owsley C. (2004). Vision-specific health-related quality of life in age-related maculopathy patients presenting for low vision services. Ophthalmic Epidemiology, 11, 131–146.PubMedCrossRef Scilley K., DeCarlo D. K., Wells J., & Owsley C. (2004). Vision-specific health-related quality of life in age-related maculopathy patients presenting for low vision services. Ophthalmic Epidemiology, 11, 131–146.PubMedCrossRef
49.
go back to reference Dong L. M., Childs A. L., Mangione C. M., Bass E. B., Bressler N. M., Hawkins B. S., Marsh M. J., Miskala P., Jaffee H. A., & McCaffrey L. A. (2004). Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4. American Journal of Ophthalmology, 138, 91–108.PubMedCrossRef Dong L. M., Childs A. L., Mangione C. M., Bass E. B., Bressler N. M., Hawkins B. S., Marsh M. J., Miskala P., Jaffee H. A., & McCaffrey L. A. (2004). Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4. American Journal of Ophthalmology, 138, 91–108.PubMedCrossRef
50.
go back to reference Maguire M. (2004). Baseline characteristics, the 25-item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT). Ophthalmology, 111, 1307–1316.PubMedCrossRef Maguire M. (2004). Baseline characteristics, the 25-item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT). Ophthalmology, 111, 1307–1316.PubMedCrossRef
51.
go back to reference Varma R., Paz S. H., Azen S. P., Klein R., Globe D., Torres M., Shufelt C., & Preston-Martin S. (2004). The Los Angeles Latino Eye Study: Design, methods, and baseline data. Ophthalmology, 111, 1121–1131.PubMedCrossRef Varma R., Paz S. H., Azen S. P., Klein R., Globe D., Torres M., Shufelt C., & Preston-Martin S. (2004). The Los Angeles Latino Eye Study: Design, methods, and baseline data. Ophthalmology, 111, 1121–1131.PubMedCrossRef
52.
go back to reference DeCarlo D. K., Scilley K., Wells J., & Owsley C. (2003). Driving habits and health-related quality of life in patients with age-related maculopathy. Optom Vis Sci, 80, 207–213.PubMedCrossRef DeCarlo D. K., Scilley K., Wells J., & Owsley C. (2003). Driving habits and health-related quality of life in patients with age-related maculopathy. Optom Vis Sci, 80, 207–213.PubMedCrossRef
53.
go back to reference Berdeaux G. H., Nordmann J. P., Colin E., & Arnould B. (2005). Vision-related quality of life in patients suffering from age-related macular degeneration. American Journal of Ophthalmology, 139, 271–279.PubMedCrossRef Berdeaux G. H., Nordmann J. P., Colin E., & Arnould B. (2005). Vision-related quality of life in patients suffering from age-related macular degeneration. American Journal of Ophthalmology, 139, 271–279.PubMedCrossRef
54.
go back to reference Brody B. L., Roch-Levecq A. C., Thomas R. G., Kaplan R. M., & Brown S. I. (2005). Self-management of age-related macular degeneration at the 6-month follow-up: A randomized controlled trial. Archives of Ophthalmology, 123, 46–53.PubMedCrossRef Brody B. L., Roch-Levecq A. C., Thomas R. G., Kaplan R. M., & Brown S. I. (2005). Self-management of age-related macular degeneration at the 6-month follow-up: A randomized controlled trial. Archives of Ophthalmology, 123, 46–53.PubMedCrossRef
55.
go back to reference Brody B. L., Roch-Levecq A. C., Gamst A. C., Maclean K., Kaplan R. M., & Brown S. I. (2002). Self-management of age-related macular degeneration and quality of life: A randomized controlled trial. Archives of Ophthalmology, 120, 1477–1483.PubMed Brody B. L., Roch-Levecq A. C., Gamst A. C., Maclean K., Kaplan R. M., & Brown S. I. (2002). Self-management of age-related macular degeneration and quality of life: A randomized controlled trial. Archives of Ophthalmology, 120, 1477–1483.PubMed
56.
go back to reference Miskala P. H., Bressler N. M., & Meinert C. L. (2004). Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration. Archives of Ophthalmology, 122, 758–766.PubMedCrossRef Miskala P. H., Bressler N. M., & Meinert C. L. (2004). Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration. Archives of Ophthalmology, 122, 758–766.PubMedCrossRef
57.
go back to reference Bansback N., Czoski-Murray C., Carlton J., Lewis G., Hughes L., Espallargues M., Brand C., & Brazier J. (2007). Determinants of health related quality of life and health state utility in patients with age related macular degeneration: The association of contrast sensitivity and visual acuity. Quality of Life Research, 16, 533–543.PubMedCrossRef Bansback N., Czoski-Murray C., Carlton J., Lewis G., Hughes L., Espallargues M., Brand C., & Brazier J. (2007). Determinants of health related quality of life and health state utility in patients with age related macular degeneration: The association of contrast sensitivity and visual acuity. Quality of Life Research, 16, 533–543.PubMedCrossRef
58.
go back to reference Pham T. Q., Cugati S., Rochtchina E., Mitchell P., Maloof A., & Wang J. J. (2007). Age-related maculopathy and cataract surgery outcomes: Visual acuity and health-related quality of life. Eye, 21, 324–330.PubMedCrossRef Pham T. Q., Cugati S., Rochtchina E., Mitchell P., Maloof A., & Wang J. J. (2007). Age-related maculopathy and cataract surgery outcomes: Visual acuity and health-related quality of life. Eye, 21, 324–330.PubMedCrossRef
59.
go back to reference Hewitt A. W., Jeganathan V. S., Kidd J. E., Pesudovs K., & Verma N. (2006). Influence of photodynamic therapy for age related macular degeneration upon subjective vision related quality of life. Graefes Archive for Clinical and Experimental Ophthalmology, 244, 972–977.CrossRef Hewitt A. W., Jeganathan V. S., Kidd J. E., Pesudovs K., & Verma N. (2006). Influence of photodynamic therapy for age related macular degeneration upon subjective vision related quality of life. Graefes Archive for Clinical and Experimental Ophthalmology, 244, 972–977.CrossRef
60.
go back to reference Armbrecht A. M., Aspinall P. A., & Dhillon B. (2004). A prospective study of visual function and quality of life following PDT in patients with wet age related macular degeneration. The British Journal of Ophthalmology 88, 1270–1273.PubMedCrossRef Armbrecht A. M., Aspinall P. A., & Dhillon B. (2004). A prospective study of visual function and quality of life following PDT in patients with wet age related macular degeneration. The British Journal of Ophthalmology 88, 1270–1273.PubMedCrossRef
61.
go back to reference Armbrecht A. M., Findlay C., Aspinall P. A., Hill A. R., & Dhillon B. (2003). Cataract surgery in patients with age-related macular degeneration: One-year outcomes. Journal of Cataract and Refractive Surgery, 29, 686–693.PubMedCrossRef Armbrecht A. M., Findlay C., Aspinall P. A., Hill A. R., & Dhillon B. (2003). Cataract surgery in patients with age-related macular degeneration: One-year outcomes. Journal of Cataract and Refractive Surgery, 29, 686–693.PubMedCrossRef
62.
go back to reference Mackenzie P. J., Chang T. S., Scott I. U., Linder M., Hay D., Feuer W. J., & Chambers K. (2002). Assessment of vision-related function in patients with age-related macular degeneration. Ophthalmology, 109, 720–729.PubMedCrossRef Mackenzie P. J., Chang T. S., Scott I. U., Linder M., Hay D., Feuer W. J., & Chambers K. (2002). Assessment of vision-related function in patients with age-related macular degeneration. Ophthalmology, 109, 720–729.PubMedCrossRef
63.
go back to reference Armbrecht A. M., Findlay C., Kaushal S., Aspinall P., Hill A. R., & Dhillon B. (2000). Is cataract surgery justified in patients with age related macular degeneration? A visual function and quality of life assessment. The British Journal of Ophthalmology, 84, 1343–1348.PubMedCrossRef Armbrecht A. M., Findlay C., Kaushal S., Aspinall P., Hill A. R., & Dhillon B. (2000). Is cataract surgery justified in patients with age related macular degeneration? A visual function and quality of life assessment. The British Journal of Ophthalmology, 84, 1343–1348.PubMedCrossRef
64.
go back to reference Scott I. U., Smiddy W. E., Schiffman J., Feuer W. J., Pappas & C. J. (1999). Quality of life of low-vison patients and the impact of low-vision services. American Journal of Ophthalmology, 128, 54–62.PubMedCrossRef Scott I. U., Smiddy W. E., Schiffman J., Feuer W. J., Pappas & C. J. (1999). Quality of life of low-vison patients and the impact of low-vision services. American Journal of Ophthalmology, 128, 54–62.PubMedCrossRef
65.
go back to reference Weih L. M., Hassell J. B., & Keeffe J. E. (2002). Assessment of the impact of vision impairment. Investigative Ophthalmology & Visual Science, 43, 927–935. Weih L. M., Hassell J. B., & Keeffe J. E. (2002). Assessment of the impact of vision impairment. Investigative Ophthalmology & Visual Science, 43, 927–935.
66.
go back to reference Keeffe J. E., McCarty C. A., Hassell J. B., & Gilbert A. G. (1999). Description and measurement of handicap caused by vision impairment. Australian and New Zealand Journal of Ophthalmology, 27, 184–186.PubMedCrossRef Keeffe J. E., McCarty C. A., Hassell J. B., & Gilbert A. G. (1999). Description and measurement of handicap caused by vision impairment. Australian and New Zealand Journal of Ophthalmology, 27, 184–186.PubMedCrossRef
67.
go back to reference Hassell J. B., Lamoureux E. L., & Keeffe J. E. (2006). Impact of age related macular degeneration on quality of life. The British Journal of Ophthalmology, 90, 593–596.PubMedCrossRef Hassell J. B., Lamoureux E. L., & Keeffe J. E. (2006). Impact of age related macular degeneration on quality of life. The British Journal of Ophthalmology, 90, 593–596.PubMedCrossRef
68.
go back to reference Lamoureux E. L., Hassell J. B., & Keeffe J. E. (2004). The determinants of participation in activities of daily living in people with impaired vision. American Journal of Ophthalmology, 137, 265–270.PubMedCrossRef Lamoureux E. L., Hassell J. B., & Keeffe J. E. (2004). The determinants of participation in activities of daily living in people with impaired vision. American Journal of Ophthalmology, 137, 265–270.PubMedCrossRef
69.
go back to reference Stevenson M. R., Hart P. M., Chakravarthy U., Mackenzie G., Bird A. C., Owens S. L., Chisholm I. H., Hall V., Houston R. F., McCulloch D. W., & Plowman N. (2005). Visual functioning and quality of life in the SubFoveal Radiotherapy Study (SFRADS): SFRADS report 2. The British Journal of Ophthalmology, 89, 1045–1051.PubMedCrossRef Stevenson M. R., Hart P. M., Chakravarthy U., Mackenzie G., Bird A. C., Owens S. L., Chisholm I. H., Hall V., Houston R. F., McCulloch D. W., & Plowman N. (2005). Visual functioning and quality of life in the SubFoveal Radiotherapy Study (SFRADS): SFRADS report 2. The British Journal of Ophthalmology, 89, 1045–1051.PubMedCrossRef
70.
go back to reference Stevenson M. R., Hart P. M., Montgomery A. M., McCulloch D. W., & Chakravarthy U. (2004). Reduced vision in older adults with age related macular degeneration interferes with ability to care for self and impairs role as carer. The British Journal of Ophthalmology, 88, 1125–1130.PubMedCrossRef Stevenson M. R., Hart P. M., Montgomery A. M., McCulloch D. W., & Chakravarthy U. (2004). Reduced vision in older adults with age related macular degeneration interferes with ability to care for self and impairs role as carer. The British Journal of Ophthalmology, 88, 1125–1130.PubMedCrossRef
71.
go back to reference Mangione C. M., Gutierrez P. R., Lowe G., Orav E. J., & Seddon J. M. (1999). Influence of age-related maculopathy on visual functioning and health-related quality of life. American Journal of Ophthalmology, 128, 45–53.PubMedCrossRef Mangione C. M., Gutierrez P. R., Lowe G., Orav E. J., & Seddon J. M. (1999). Influence of age-related maculopathy on visual functioning and health-related quality of life. American Journal of Ophthalmology, 128, 45–53.PubMedCrossRef
72.
go back to reference Lane S. S., Kuppermann B. D., Fine I. H., Hamill M. B., Gordon J. F., Chuck R. S., Hoffman R. S., Packer M., & Koch D. D. (2004). A prospective multicenter clinical trial to evaluate the safety and effectiveness of the implantable miniature telescope. American Journal of Ophthalmology, 137, 993–1001.PubMedCrossRef Lane S. S., Kuppermann B. D., Fine I. H., Hamill M. B., Gordon J. F., Chuck R. S., Hoffman R. S., Packer M., & Koch D. D. (2004). A prospective multicenter clinical trial to evaluate the safety and effectiveness of the implantable miniature telescope. American Journal of Ophthalmology, 137, 993–1001.PubMedCrossRef
73.
go back to reference Hazel C. A., Petre K. L., Armstrong R. A., Benson M. T., & Frost N. A. (2000). Visual function and subjective quality of life compared in subjects with acquired macular disease. Investigative Ophthalmology & Visual Science, 41, 1309–1315. Hazel C. A., Petre K. L., Armstrong R. A., Benson M. T., & Frost N. A. (2000). Visual function and subjective quality of life compared in subjects with acquired macular disease. Investigative Ophthalmology & Visual Science, 41, 1309–1315.
74.
go back to reference Reeves B. C., Harper R. A., & Russell W. B. (2004). Enhanced low vision rehabilitation for people with age related macular degeneration: A randomised controlled trial. The British Journal of Ophthalmology, 88, 1443–1449.PubMedCrossRef Reeves B. C., Harper R. A., & Russell W. B. (2004). Enhanced low vision rehabilitation for people with age related macular degeneration: A randomised controlled trial. The British Journal of Ophthalmology, 88, 1443–1449.PubMedCrossRef
75.
go back to reference Krummenauer F., Braun M., & Dick H. B. (2005). Clinical outcome and subjective quality of life after photodynamic therapy in patients with age-related macular degeneration. European Journal of Ophthalmology, 15, 74–80.PubMed Krummenauer F., Braun M., & Dick H. B. (2005). Clinical outcome and subjective quality of life after photodynamic therapy in patients with age-related macular degeneration. European Journal of Ophthalmology, 15, 74–80.PubMed
76.
go back to reference Lundstrom M., Brege K. G., Floren I., Lundh B., Stenevi U., & Thorburn W. (2002). Cataract surgery and quality of life in patients with age related macular degeneration. The British Journal of Ophthalmology, 86, 1330–1335.PubMedCrossRef Lundstrom M., Brege K. G., Floren I., Lundh B., Stenevi U., & Thorburn W. (2002). Cataract surgery and quality of life in patients with age related macular degeneration. The British Journal of Ophthalmology, 86, 1330–1335.PubMedCrossRef
77.
go back to reference Carta A., Braccio L., Belpoliti M., Soliani L., Sartore F., Gandolfi S. A., & Maraini G. (1998). Self-assessment of the quality of vision: Association of questionnaire score with objective clinical tests. Current Eye Research, 17, 506–511.PubMedCrossRef Carta A., Braccio L., Belpoliti M., Soliani L., Sartore F., Gandolfi S. A., & Maraini G. (1998). Self-assessment of the quality of vision: Association of questionnaire score with objective clinical tests. Current Eye Research, 17, 506–511.PubMedCrossRef
78.
go back to reference Gupta S. K., Viswanath K., Thulasiraj R. D., Murthy G. V., Lamping D. L., Smith S. C., Donoghue M., & Fletcher A. E. (2005). The development of the Indian vision function questionnaire: Field testing and psychometric evaluation. The British Journal of Ophthalmology, 89, 621–627.PubMedCrossRef Gupta S. K., Viswanath K., Thulasiraj R. D., Murthy G. V., Lamping D. L., Smith S. C., Donoghue M., & Fletcher A. E. (2005). The development of the Indian vision function questionnaire: Field testing and psychometric evaluation. The British Journal of Ophthalmology, 89, 621–627.PubMedCrossRef
79.
go back to reference Alonso J., Espallargues M., Andersen T. F., Cassard S. D., Dunn E., Bernth-Petersen P., Norregaard J. C., Black C., Steinberg E. P., & Anderson G. F. (1997). International applicability of the VF-14. An index of visual function in patients with cataracts. Ophthalmology, 104, 799–807.PubMed Alonso J., Espallargues M., Andersen T. F., Cassard S. D., Dunn E., Bernth-Petersen P., Norregaard J. C., Black C., Steinberg E. P., & Anderson G. F. (1997). International applicability of the VF-14. An index of visual function in patients with cataracts. Ophthalmology, 104, 799–807.PubMed
80.
go back to reference Crabtree H. L., Hildreth A. J., O’Connell J. E., Phelan P. S., Allen D., & Gray C. S. (1999). Measuring visual symptoms in British cataract patients: The cataract symptom scale. The British Journal of Ophthalmology, 83, 519–523.PubMedCrossRef Crabtree H. L., Hildreth A. J., O’Connell J. E., Phelan P. S., Allen D., & Gray C. S. (1999). Measuring visual symptoms in British cataract patients: The cataract symptom scale. The British Journal of Ophthalmology, 83, 519–523.PubMedCrossRef
81.
go back to reference Fitzpatrick R., Davey C., Buxton M. J., & Jones D. R. (1998). Evaluating patient-based outcome measures for use in clinical trials. Health Technology Assessment, 2, i, iv–1, 74. Fitzpatrick R., Davey C., Buxton M. J., & Jones D. R. (1998). Evaluating patient-based outcome measures for use in clinical trials. Health Technology Assessment, 2, i, iv–1, 74.
82.
go back to reference Pallant J. F., & Tennant A. (2007). An introduction to the Rasch measurement model: An example using the Hospital Anxiety and Depression Scale (HADS). The British Journal of Clinical Psychology, 46, 1–18.PubMedCrossRef Pallant J. F., & Tennant A. (2007). An introduction to the Rasch measurement model: An example using the Hospital Anxiety and Depression Scale (HADS). The British Journal of Clinical Psychology, 46, 1–18.PubMedCrossRef
83.
go back to reference Massof R. W., & Fletcher D. C. (2001). Evaluation of the NEI visual functioning questionnaire as an interval measure of visual ability in low vision. Vision Research, 41, 397–413.PubMedCrossRef Massof R. W., & Fletcher D. C. (2001). Evaluation of the NEI visual functioning questionnaire as an interval measure of visual ability in low vision. Vision Research, 41, 397–413.PubMedCrossRef
84.
go back to reference Langelaan M., van Nispen R. M., Knol D. L., Moll A. C., de Boer M. R., Wouters B., & van Rens G. H. (2007). Visual Functioning Questionnaire: Reevaluation of psychometric properties for a group of working-age adults. Optometry and Vision Science 84, 775–784.PubMedCrossRef Langelaan M., van Nispen R. M., Knol D. L., Moll A. C., de Boer M. R., Wouters B., & van Rens G. H. (2007). Visual Functioning Questionnaire: Reevaluation of psychometric properties for a group of working-age adults. Optometry and Vision Science 84, 775–784.PubMedCrossRef
85.
go back to reference Denny F., Marshall A. H., Stevenson M. R., Hart P. M., & Chakravarthy U. (2007). Rasch analysis of the daily living tasks dependent on vision (DLTV). Investigative Ophthalmology & Visual Science, 48, 1976–1982.CrossRef Denny F., Marshall A. H., Stevenson M. R., Hart P. M., & Chakravarthy U. (2007). Rasch analysis of the daily living tasks dependent on vision (DLTV). Investigative Ophthalmology & Visual Science, 48, 1976–1982.CrossRef
86.
go back to reference Velozo C. A., Lai J. S., Mallinson T., & Hauselman E. (2000). Maintaining instrument quality while reducing items: Application of Rasch analysis to a self-report of visual function. Journal of Outcome Measurement, 4, 667–680.PubMed Velozo C. A., Lai J. S., Mallinson T., & Hauselman E. (2000). Maintaining instrument quality while reducing items: Application of Rasch analysis to a self-report of visual function. Journal of Outcome Measurement, 4, 667–680.PubMed
Metagegevens
Titel
Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools
Auteurs
Robert P. Finger
Monika Fleckenstein
Frank G. Holz
Hendrik P. N. Scholl
Publicatiedatum
01-05-2008
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 4/2008
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-008-9327-4